Objective: There is limited research on reliable and clinically useful predictors of electroconvulsive therapy (ECT) use. We aimed to examine factors that predict ECT use in an inpatient psychiatric population.
Design: Retrospective analysis of provincial database for inpatient psychiatry.
Methods: This study is a retrospective analysis of a provincial database for inpatient psychiatry. The study includes all psychiatric inpatients 18 years or older in Ontario, Canada, assessed with the Resident Assessment Instrument for Mental Health (RAI-MH) within the first 3 days of admission between 2009 and 2014 (n = 153,023). The RAI-MH is a validated assessment tool which includes a breadth of information on symptoms, self-harm, functioning, social support, comorbid medical diagnoses, and risk appraisal. Multivariable analyses were performed using SAS.
Results: One hundred forty-five thousand seven hundred (95.2%) of patients admitted had no history of ECT treatment and were not scheduled to receive ECT. A total of 7323 (or 4.8% of the patient population) had either a history of ECT use or were scheduled to receive ECT. Overall rate of ECT use was highest in patients with a provisional diagnosis of mood disorder (7.2%) compared with schizophrenia/other psychotic disorder (3.1%) or substance-related disorder (1.7%). Women were more likely to receive ECT compared with men (overall rates of ECT use 6.2% and 3.4%, respectively). Overall rate of ECT use increased significantly with increasing age. Number of prior hospitalizations was also a strong predictor of ECT use. Conversely, patients with elevated Risk of Harm to Others, schizophrenia, or a substance use disorder were all significantly less likely to receive ECT. All variables examined were statistically significant (P < 0.0001). Higher Severity of Self Harm Scores predicted past use, but not scheduled use of ECT.
Conclusions: This is the largest study to date on predictors of ECT use. Utilization of RAI-MH is a novel and clinically useful method for evaluating predictors of ECT use. Predictors of ECT use within an inpatient population include: presence of a mood disorder, female sex, older age, low risk of harm to others, number of lifetime hospitalizations, lack of substance use disorder, and inability to care for self.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/YCT.0000000000000461 | DOI Listing |
J Affect Disord
January 2025
Department of Anesthesiology and Intensive Care Medicine, Medical University of Innsbruck, Austria. Electronic address:
Background: Anesthesia depth influences seizure quality in patients undergoing electroconvulsive therapy (ECT). EEG-based neuromonitoring has been shown to detect adequate anesthesia depth for ECT. Anesthesia depth-guided ECT management may therefore be a reliable alternative to the predetermined anesthesia-to-stimulation time interval.
View Article and Find Full Text PDFJ ECT
January 2025
Department of Psychiatry, Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India.
Background: Resistant auditory verbal hallucination (AVH) remains a disabling symptom in schizophrenia. Transcranial direct current stimulation (tDCS) and its more targeted variant, high-definition tDCS (HD-tDCS), have shown promising results in reducing AVH. We aimed to determine the effects of adjunctive HD-tDCS on various dimensions of AVH in patients with schizophrenia.
View Article and Find Full Text PDFJ ECT
January 2025
From the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA.
Background: Electroconvulsive therapy (ECT) is an effective treatment for treatment-resistant depression (TRD). There are limited data on the improvement of anxiety symptoms in patients receiving ECT for TRD.
Objective: The aim of the study was to examine the extent to which anxiety symptom severity improves, relative to improvements in depressive symptoms, in TRD patients receiving an acute course of ECT.
There remains a scarcity of studies to evaluate the treatment effect of electroconvulsive therapy (ECT). Functional near-infrared spectroscopy (fNIRS) offers a cost-effective method to measure cerebral hemodynamics. This study used fNIRS to evaluate the effect of ECT in patients suffering from schizophrenia or bipolar disorder (manic phase).
View Article and Find Full Text PDFJ ECT
January 2025
From the Department of Psychiatry, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
Objectives: This study investigates repeated oral esketamine as a substitution strategy for maintenance electroconvulsive therapy (M-ECT) in eight patients with treatment-resistant depression (TRD).
Methods: In a 6-week dosing phase, esketamine was titrated from 0.5 or 1.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!